Publication date: Aug 09, 2024
During the new coronavirus disease 2019 (COVID-19) pandemic, there are numerous symptoms in the skeletal muscular system, such as decreased skeletal muscle mass, strength, and muscle function, which are the main manifestations of sarcopenia. To investigate the impact of the COVID-19 pandemic on sarcopenia from the perspectives of COVID-19 pandemic lockdown and COVID-19 infection, we conducted this study. We searched for literature related to COVID-19 and sarcopenia published in PubMed, Embase, Cochrane Library, and Web of Science. Two researchers independently searched and screened the articles, extracted data, and assessed the quality of the final included literature. RevMan 5. 4 was used for meta-analysis. A total of 8 articles with a total of 1145 patients were included. There was a significant difference in SARC-F scores (MD = 0. 67, 95%CI = [0. 41, 0. 93], Z = 5. 00, P
Concepts | Keywords |
---|---|
Coronavirus | COVID-19 |
Library | Hand Strength |
Pandemic | Humans |
Pubmed | Pandemics |
Quarantine | |
Risk Factors | |
Sarcopenia | |
SARS-CoV-2 |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 pandemic |
disease | MESH | sarcopenia |
disease | MESH | infection |
disease | IDO | quality |
disease | MESH | Long Covid |